219 related articles for article (PubMed ID: 37872575)
1. Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Yuwen T; Yang Z; Cai G; Feng G; Liu Q; Fu H
Reprod Biol Endocrinol; 2023 Oct; 21(1):95. PubMed ID: 37872575
[TBL] [Abstract][Full Text] [Related]
2. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
3. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
4. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
5. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
6. Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI.
He Y; Li R; Yin J; Yang Z; Wang Y; Chen L; Yang S; Qiao J
Front Endocrinol (Lausanne); 2023; 14():1204623. PubMed ID: 37693353
[TBL] [Abstract][Full Text] [Related]
7. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
[TBL] [Abstract][Full Text] [Related]
8. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006105. PubMed ID: 25406011
[TBL] [Abstract][Full Text] [Related]
9. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
10. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
Bhide P; Pundir J; Gudi A; Shah A; Homburg R; Acharya G
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1235-1244. PubMed ID: 30993683
[TBL] [Abstract][Full Text] [Related]
11. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
12. Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis.
Wu Y; Tu M; Huang Y; Liu Y; Zhang D
JAMA Netw Open; 2020 Aug; 3(8):e2011995. PubMed ID: 32744629
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.
Liu X; Han Y; Wang X; Zhang Y; Du A; Yao R; Lv J; Luo H
BMC Pregnancy Childbirth; 2022 Apr; 22(1):279. PubMed ID: 35366830
[TBL] [Abstract][Full Text] [Related]
14. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology.
Tal R; Seifer CM; Khanimov M; Seifer DB; Tal O
Reprod Biol Endocrinol; 2020 Mar; 18(1):20. PubMed ID: 32156287
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-Müllerian hormone levels are associated with perinatal outcomes in women undergoing IVF/ICSI: A multicenter retrospective cohort study.
He YC; Su KZ; Cai J; Meng QX; Wu YT; Huang HF
Front Endocrinol (Lausanne); 2023; 14():1081069. PubMed ID: 36896183
[TBL] [Abstract][Full Text] [Related]
16. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
[TBL] [Abstract][Full Text] [Related]
17. Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study.
Si M; Qi X; Zhen X; Yang C; Tian T; Long X; Qiao J
Adv Ther; 2023 Sep; 40(9):3971-3985. PubMed ID: 37395872
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic ovarian drilling before IVF/ICSI in polycystic ovarian syndrome patients with high antimullarian hormone.
Abdelhafez MS; Shams M; Abdel-Razik MM; Wageh A
J Gynecol Obstet Hum Reprod; 2022 Mar; 51(3):102324. PubMed ID: 35063718
[TBL] [Abstract][Full Text] [Related]
19. High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment.
Sun TC; Zhou SJ; Song LL; Li JH; Chen X; Tian L
JBRA Assist Reprod; 2021 Apr; 25(2):266-271. PubMed ID: 33710839
[TBL] [Abstract][Full Text] [Related]
20. Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.
Arabzadeh S; Hossein G; Rashidi BH; Hosseini MA; Zeraati H
Ann Saudi Med; 2010; 30(6):442-7. PubMed ID: 20940513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
